Menu
GeneBe

rs34272112

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000096.4(CP):c.3182-4A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,416,672 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 13 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 3 hom. )

Consequence

CP
NM_000096.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.001273
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.599
Variant links:
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
HPS3 (HGNC:15597): (HPS3 biogenesis of lysosomal organelles complex 2 subunit 1) This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 3-149173734-T-C is Benign according to our data. Variant chr3-149173734-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 128842.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-149173734-T-C is described in Lovd as [Likely_benign]. Variant chr3-149173734-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00757 (1152/152216) while in subpopulation AFR AF= 0.0254 (1055/41550). AF 95% confidence interval is 0.0241. There are 13 homozygotes in gnomad4. There are 561 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPNM_000096.4 linkuse as main transcriptc.3182-4A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000264613.11
HPS3NM_032383.5 linkuse as main transcript downstream_gene_variant ENST00000296051.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPENST00000264613.11 linkuse as main transcriptc.3182-4A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_000096.4 P1
HPS3ENST00000296051.7 linkuse as main transcript downstream_gene_variant 1 NM_032383.5 P1Q969F9-1

Frequencies

GnomAD3 genomes
AF:
0.00753
AC:
1146
AN:
152098
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00472
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.00384
GnomAD3 exomes
AF:
0.00197
AC:
353
AN:
178860
Hom.:
0
AF XY:
0.00154
AC XY:
147
AN XY:
95410
show subpopulations
Gnomad AFR exome
AF:
0.0244
Gnomad AMR exome
AF:
0.00189
Gnomad ASJ exome
AF:
0.000344
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000134
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000248
Gnomad OTH exome
AF:
0.00104
GnomAD4 exome
AF:
0.000781
AC:
988
AN:
1264456
Hom.:
3
Cov.:
20
AF XY:
0.000710
AC XY:
448
AN XY:
631420
show subpopulations
Gnomad4 AFR exome
AF:
0.0204
Gnomad4 AMR exome
AF:
0.00195
Gnomad4 ASJ exome
AF:
0.000374
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000148
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000163
Gnomad4 OTH exome
AF:
0.00266
GnomAD4 genome
AF:
0.00757
AC:
1152
AN:
152216
Hom.:
13
Cov.:
32
AF XY:
0.00754
AC XY:
561
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.0254
Gnomad4 AMR
AF:
0.00471
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000177
Gnomad4 OTH
AF:
0.00380
Alfa
AF:
0.00373
Hom.:
1
Bravo
AF:
0.00882
Asia WGS
AF:
0.00203
AC:
7
AN:
3466

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Deficiency of ferroxidase Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 28, 2020- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Hermansky-Pudlak syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
Cadd
Benign
12
Dann
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34272112; hg19: chr3-148891521; API